Coastal Bridge Advisors LLC Has $2.27 Million Stake in SPDR S&P Biotech ETF $XBI

Coastal Bridge Advisors LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,629 shares of the exchange traded fund’s stock after selling 7,770 shares during the period. Coastal Bridge Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,267,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Ameriprise Financial Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares during the period. Meitav Investment House Ltd. raised its holdings in SPDR S&P Biotech ETF by 2,199.6% in the 2nd quarter. Meitav Investment House Ltd. now owns 400,454 shares of the exchange traded fund’s stock valued at $33,229,000 after acquiring an additional 383,040 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock valued at $882,218,000 after acquiring an additional 268,399 shares during the period. Marshall Wace LLP grew its holdings in shares of SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of SPDR S&P Biotech ETF by 68.5% during the 2nd quarter. Clal Insurance Enterprises Holdings Ltd now owns 428,000 shares of the exchange traded fund’s stock worth $35,494,000 after purchasing an additional 174,000 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 2.0%

XBI stock opened at $125.94 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $132.09. The business has a 50-day simple moving average of $123.36 and a 200 day simple moving average of $106.71. The company has a market cap of $8.43 billion, a PE ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.